The safety data that allowed FDA to endorse the use of Pfizer's mRNA vaccine in the US in adolescents aged 12-15 years included 2,260 participants aged 12-15 years enrolled in a randomized, double-blind, placebo-controlled trial. * this is how scientific evidence is made.